Trials / Completed
CompletedNCT03791008
Assessment of Feasibility and Acceptability of Personalized Breast Cancer Screening
Personalized Breast Cancer Screening: Assessment of Its Feasibility and Acceptability in the National Health System
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 387 (actual)
- Sponsor
- Institut de Recerca Biomèdica de Lleida · Academic / Other
- Sex
- Female
- Age
- 40 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The overall objective is to assess the acceptability and feasibility of offering personalized breast cancer (BC) screening. The specific objectives are: 1) To design an information system; 2) To evaluate the barriers and facilitators of the coordination of health care services and the screening program; 3) To develop a proof of concept of personalized screening; and 4) To evaluate cost-effectiveness. Methodology: 1. Prototype information system with basal and longitudinal variables relevant to a personalized screening system; 2. Qualitative study with focus groups and survey. The attitude and acceptability on a sample of 210 health professionals will be assessed; 3. Prospective observational study, for proof of concept. Participants will be professionals working in Primary Care, Population Breast Screening Program, or Hospital Breast Unit. It will include 385 women, aged 40-50 from the city of Lleida. Various indicators of acceptability and feasibility will be assessed in women and health professionals; 4. Probabilistic analytical models will be used to evaluate cost-effectiveness. The present protocol addresses the specific objective number 3, the proof of concept of personalised screening. Expected results: The investigators expect to provide valuable and necessary information for the design of personalized screening.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Risk based screening | Breast cancer risk measurement, screening recommendations and shared decision making |
Timeline
- Start date
- 2019-01-30
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
- First posted
- 2019-01-02
- Last updated
- 2022-03-31
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT03791008. Inclusion in this directory is not an endorsement.